SR 299
A Resolution designating May 14, 2026, as "IgAN Awareness Day" in Pennsylvania.
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Bill overview
This resolution designates May 14, 2026, as "IgAN Awareness Day" in Pennsylvania. The resolution highlights the prevalence of chronic kidney disease, particularly IgAN (immunoglobulin A nephropathy), and the challenges associated with its diagnosis and treatment. It emphasizes the need for increased awareness among patients, providers, and policymakers to improve access to screening, diagnosis, and treatment, as well as the availability of new therapies for this condition.
Key provisions
- Designates May 14, 2026, as IgAN Awareness Day in Pennsylvania.
- Acknowledges the significant prevalence of chronic kidney disease, including IgAN.
- Highlights the difficulties in diagnosing IgAN due to its rarity and the limited number of specialists.
- Notes the increased risk of progression to end-stage renal disease (ESRD) in patients with IgAN.
- Recognizes the growing availability of new drugs to slow the progression of CKD and IgAN.
- Encourages broader screening for kidney disease through tests like serum creatinine and urine albuminuria creatinine ratio tests.
- Calls for policies to improve access to screening, diagnosis, and treatment for kidney disease.
- Promotes awareness and support for patients, caregivers, and advocates working to improve care for kidney disease.
Who is affected
- Individuals with chronic kidney disease (CKD)
- Individuals with IgAN (immunoglobulin A nephropathy)
- Patients with glomerular diseases
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Christine Tartaglione
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yours